Evidence map›Paper›PMID 35282041›Full record

ArticleAnnals of translational medicine2022

Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study.

Huimin Wang, Dianzhen Li, Chunyan Wang, Xiaobin Wang, Mingxin Yu, Xin Zhang, Liankun Li, Qingdong Zeng, Zaiqiu Long, Wei Zheng and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. New progress and challenge in gynecological cancer.Annals of translational medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Huimin Wang *Department of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Dianzhen Li *Department of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Chunyan WangDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Xiaobin WangDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Mingxin YuDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Xin ZhangDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Liankun LiDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Qingdong ZengDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Zaiqiu LongDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Wei ZhengDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Guangcong LiuDepartment of Epidemiology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Danbo WangDepartment of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Liaoning Cancer Hospital & Institute · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To investigate the survival outcomes of abdominal radical hysterectomy (ARH), laparoscopic radical hysterectomy (LRH), and vaginal-assisted laparoscopic radical hysterectomy (VALRH) in the treatment of cervical cancer patients. Methods: This was a retrospective study. We collected the clinical data of 654 patients with cervical cancer (406 ARH, 172 LRH, and 76 VALRH), then compared the effects of different surgical methods on recurrence and survival. Results: Total overall survival (OS) were no significant differences in three groups (P>0.05). Total disease-free survival (DFS) was significantly higher in ARH group than in LRH group [hazard ratio (HR) =2.8, 95% confidence interval (CI): 1.199-3.607, P=0.004]; however, there were no significant differences between the VALRH (94.7%) and ARH (93.3%) groups. Subgroup stratification analysis showed that the overall recurrence rate in LRH group was significantly higher than that of the ARH groups for patients with a tumor size from ≥2 to <4 cm, negative postoperative lymph nodes, and no postoperative adjuvant therapy (all P<0.05). However, in the subgroup with tumor sizes of ≥2, <4, and ≥4 cm, no matter whether the lymph nodes were positive or not, and those with no postoperative supplementary adjuvant therapy, LRH was associated with a significantly higher local pelvic recurrence rate than ARH (all P<0.05). No significant differences between VALRH and ARH in any of the subgroup analyses (all P>0.05). A Cox analysis indicated that LRH increased the risk of overall and local pelvic recurrence after surgery compared with ARH (HR =2.338, 95% CI: 1.186-4.661, P=0.014; HR =10.313, 95% CI: 2.839-37.460, P<0.001); however, no significant difference between VALRH and ARH (all P>0.05). Sensitivity analysis of surgeons did not change the conclusions. Conclusions: Our analyses showed that the local pelvic recurrence rates and overall recurrence rates of LRH were significantly higher than ARH. VALRH could avoid tumor intraperitoneal exposure and achieve the same tumor prognosis as open surgery. By improving the standardization of minimally invasive surgery for early cervical cancer and paying close attention to the tumor-free concept, minimally invasive radical hysterectomy may achieve the same tumor outcome as open surgery.

Indexed as

abdominal radical hysterectomy (ARH)cervical cancerefficacylaparoscopic radical hysterectomy (LRH)Vaginal-assisted laparoscopic radical hysterectomy (VALRH)

Identifiers

PMID35282041
PMCPMC8848440
OpenAlexW4205487521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.